Jci_page_head_homepage_01 Jci_page_head_homepage_02
Masaya Kobayashi, Mi-Na Kweon, Hirotaka Kuwata, Robert D. Schreiber, Hiroshi Kiyono, Kiyoshi Takeda, Shizuo Akira
Published in Volume 111, Issue 9
J Clin Invest. 2003; 111(9):1297–1308 doi:10.1172/JCI17085
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

IBDs in Stat1/Stat3 double-deficient mice. (a-d) Histologic examination of the colons of (a) control, (b) Stat1-deficient, (c) Stat3 mutant, and (d) Stat1/Stat3 double-mutant mice at 8 weeks. H&E staining is shown. ×20. (e)The colitis scores shown for individual mice at 16 weeks of age were total scores for individual sections as described in Methods. The severity of colitis in Stat1/Stat3 double-mutant mice was significantly but only partially improved compared with Stat3 mutant mice (**P < 0.01). *P < 0.001 versus group of control mice.